Cento, V., & Perno, C. F. (2021). Dolutegravir Plus Lamivudine Two-Drug Regimen: Safety, Efficacy and Diagnostic Considerations for Its Use in Real-Life Clinical Practice—A Refined Approach in the COVID-19 Era. Diagnostics (Basel).
Chicago Style citaatCento, Valeria, en Carlo Federico Perno. "Dolutegravir Plus Lamivudine Two-Drug Regimen: Safety, Efficacy and Diagnostic Considerations for Its Use in Real-Life Clinical Practice—A Refined Approach in the COVID-19 Era." Diagnostics (Basel) 2021.
MLA citatieCento, Valeria, en Carlo Federico Perno. "Dolutegravir Plus Lamivudine Two-Drug Regimen: Safety, Efficacy and Diagnostic Considerations for Its Use in Real-Life Clinical Practice—A Refined Approach in the COVID-19 Era." Diagnostics (Basel) 2021.